Clinical and Translational Imaging

Fluorescent imaging of bacterial infections and recent advances made with multimodal radiopharmaceuticals

Recent developments of prostate-specific membrane antigen (PSMA)-specific radiopharmaceuticals for precise imaging and therapy of prostate cancer: an overview

Open letter to journal editors on: International Consensus Radiochemistry Nomenclature Guidelines

Evidence-based indications for the planning of PET or PET/CT capacities are needed

Current status of SSR-directed imaging and therapy in meningioma

PSMA-PET/CT imaging in prostate cancer: why and when

FDG-PET/CT as a diagnostic tool in vascular graft infection: a systematic review and meta-analysis

HTA in nuclear medicine: [68Ga]PSMA PET/CT for patients with prostate cancer

68Ga-DOTA-peptides PET/MRI in pancreatico-duodenal neuroendocrine tumours: a flash pictorial essay on assets and lacks

Liquid biopsies and molecular imaging: friends or foes?

Integration of imaging biomarkers into systems biomedicine: a renaissance for medical imaging

The value of yttrium-90 PET/CT after hepatic radioembolization: a pictorial essay

Peptide receptor radionuclide therapy plus somatostatin analogues for a neuroendocrine tumour combined and maintenance treatment

PET/MRI for neuroendocrine tumors: a match made in heaven or just another hype?

Peptide receptor radionuclide therapy after NETTER-1 clinical trial: what should not be left behind

Clinical and translational imaging keeps growing: thanks to its board members, authors and readership

The role of molecular imaging in the frame of the revised dementia with Lewy body criteria

Sentinel lymph node biopsy in oral–oropharyngeal squamous cell carcinoma: standards, new technical procedures, and clinical advances

A look ahead: future directions of SSR-directed imaging and therapy in meningioma

PET biomarkers and probes for treatment response assessment in glioblastoma: a work in progress

Multimodal therapy of advanced differentiated thyroid cancer, with emphasis on the role of radioiodine

Towards consensus in acquisition and image analysis of PET and SPECT in the assessment of cardiac sympathetic innervation: a mini-review

PET imaging of vulnerable coronary artery plaques

Hybrid cardiac PET/MR: the value of multiparametric assessment in cardiac sarcoidosis

Advanced approaches to imaging primary breast cancer: an update

Predictive value of pre-treatment FDG PET in patients with non-Hodgkin lymphoma treated with radioimmunotherapy: a systematic review

Cardiac amyloidosis

Targeting prostate cancer with the anti-PSMA scFvD2B: a theranostic promise for nuclear medicine

18F-FDG in the presurgical evaluation of epilepsies: a pictorial essay

Head-to-head comparison between 18F-FDG PET/CT and PET/MRI in breast cancer

Role of thyroglobulin in the management of patients with differentiated thyroid cancer

Nuclear medicine and immunotherapy: many questions but not many answers yet

Diagnostic performance of FDG PET in large vessel vasculitis

Management of hyperglycemia in oncological patients scheduled for an FDG-PET/CT examination

Correction to: The role of molecular imaging in the frame of the revised dementia with Lewy body criteria

18F-FDG in the differential diagnosis of neurodegenerative dementias

Detection rate of radiolabelled choline PET or PET/CT in hepatocellular carcinoma: an updated systematic review and meta-analysis

The eye of nuclear medicine

Investigations of possible links between Alzheimer’s disease and type 2 diabetes mellitus by positron emission tomography: a systematic review